• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


8.8500 USD 0.0400 0.45%

As of 20:10:00 ET on 07/23/2014.

Snapshot for Aradigm Corp (ARDM)

Open: 8.8500 Day's Range: 8.8500 - 8.8500 Volume: 305
Previous Close: 8.8900 52wk Range: 6.4450 - 15.9600 1-Yr Rtn: +23.26%

Stock Chart for ARDM

No chart data available.
  • ARDM:US 8.8500
  • 1D
  • 1M
  • 1Y
Interactive ARDM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARDM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 36.8750
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6733
Est. EPS (USD) (12/2014) 0.2400
Est. PEG Ratio -
Market Cap (M USD) 130.17
Shares Outstanding (M) 14.71
30 Day Average Volume 6,462
Price/Book (mrq) 3.1233
Price/Sale (ttm) 6.8355
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARDM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ARDM

Aradigm Corporation develops novel pulmonary drug delivery systems. The Company's systems are designed to enhance the delivery and effectiveness of a number of existing and development stage drugs and reduce the need for injectable drug therapy. Aradigm's principal product development programs are based on its AERx pulmonary drug delivery system.

Igor GondaPresident/CEOJuergen FroehlichChief Medical Officer
Nancy E PecotaVP:Finance/CFO
More Company Profile & Key Executives for ARDM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil